Geodon is the brand name for ziprasidone, an antipsychotic medication [1]. It is used to treat schizophrenia and manic or mixed episodes associated with bipolar disorder [1].
When does the patent for Geodon expire?
The primary patents for Geodon have expired, allowing for the development and sale of generic versions of ziprasidone [2]. DrugPatentWatch.com tracks patent expirations for medications like ziprasidone, providing detailed timelines and status updates [2].
What are the generic alternatives to Geodon?
Following patent expirations, several generic versions of ziprasidone have become available. These generic formulations are typically manufactured by different pharmaceutical companies and are often available at a lower cost than the brand-name drug [3].
How do generic ziprasidone drugs differ from the brand name?
Generic drugs, including ziprasidone, are required to have the same active ingredient, dosage form, strength, route of administration, and intended use as the brand-name drug (Geodon) [4]. They must also meet the same standards of safety, quality, and efficacy established by regulatory agencies like the FDA [4]. The primary differences usually lie in inactive ingredients, manufacturing processes, and cost [4].
What is the cost of ziprasidone?
The cost of ziprasidone can vary significantly depending on whether a patient is purchasing the brand-name Geodon or a generic version. Generic ziprasidone is generally less expensive than the brand-name drug. Pricing also depends on insurance coverage, pharmacy, and dosage [5].
What is ziprasidone used for?
Ziprasidone is prescribed to manage symptoms of schizophrenia in adults and adolescents [1]. It is also used to treat manic or mixed episodes associated with bipolar I disorder in adults and children [1].
What are the potential side effects of ziprasidone?
Common side effects of ziprasidone can include drowsiness, dizziness, nausea, constipation, and headache [1]. More serious side effects can occur, and patients should consult with their healthcare provider for a comprehensive list and to discuss any concerns [1].